uniQure
QURE
#6052
Rank
C$1.28 B
Marketcap
C$20.52
Share price
-5.32%
Change (1 day)
9.22%
Change (1 year)

Earnings for uniQure (QURE)

Earnings in 2025 (TTM): -C$0.32 Billion

According to uniQure's latest financial reports the company's current earnings are C$15.75 Million. In 2024 the company made an earning of -C$0.33 Billion, an increase over its 2023 earnings that were of -C$0.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for uniQure from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.32 Billion-3.82%
2024 -C$0.33 Billion-22.65%
2023 -C$0.43 Billion139.01%
2022 -C$0.18 Billion-138.54%
2021 C$0.46 B-335.29%
2020 -C$0.2 Billion13.88%
2019 -C$0.18 Billion49.51%
2018 -C$0.12 Billion4.55%
2017 -C$0.12 Billion12.65%
2016 -C$98 Million-9.59%
2015 -C$0.11 Billion66.95%
2014 -C$64.92 Million30.8%
2013 -C$49.64 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
C$12.46 B-4,093.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.69 B-3,525.82%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
-C$0.16 Billion-51.49%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-C$0.28 Billion-11.09%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.67 B-314.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-C$0.96 Billion 204.63%๐Ÿ‡บ๐Ÿ‡ธ USA